TipHub

109.09

+2.13 +1.99%

29 Jul 2026

BSE Listed

GSM · GSM 0 · ESM · ESM 2
What does GSM · GSM 0 · ESM · ESM 2 mean?
BSE · Graded Surveillance Measure (GSM 0)GSM targets fundamentally weak companies whose price doesn't square with their financials (tiny net worth or negative/extreme P/E). Practical meaning: the exchange doubts the price is backed by the business. Stage 0 is a watchlist; each higher stage makes the stock progressively harder to trade — tighter bands, full upfront margin, weekly-only trading, and at Stage IV no upward price movement at all. Exiting requires a quarterly review finding the criteria no longer met.Criteria: Shortlisted on objective financial parameters — net worth, net fixed assets, price-to-earnings multiple and market capitalisation. Stage 0 = base surveillance watchlist (identified under GSM, no graded price restriction yet); Stages I–VI add escalating curbs (price band, 100% margin, periodic call auction, settlement on a gross/trade-for-trade basis, no upward price movement).
BSE · Enhanced Surveillance Measure (ESM 2)ESM is the micro/small-cap ramp brake: it fires when a sub-₹1000cr stock's price variation is extreme versus its peer universe, or it's loss-making with a stretched valuation. Practical meaning: intraday speculation is shut off (Trade-for-Trade — every purchase must be taken to delivery), margins go to 100%, and at Stage II price discovery moves to periodic call auctions inside a 2% band.Criteria: Micro / small-cap companies (main-board market-cap below ₹500 cr) shortlisted on objective price parameters — high-low price variation, close-to-close price variation and standard deviation. Stage I = 100% margin + a ≤5% price band + Trade-for-Trade; Stage II = a 2% price band + periodic call auction.Exchange notice · 2026-06-17

Parmax Pharma Limited (540359)

Volume: 0Avg Vol 1W: 34,301Avg Vol 1M: 15,60352W Range:22.6109.2
Key Ratios
Checked 1h ago
Market Cap₹40 Cr
Current Price₹109.09
Previous Close₹106.96
High / Low (52w)₹109.2 / ₹22.6
Volume0
Avg Vol (1W)34,301
Avg Vol (1M)15,603
Stock P/E
Book Value₹-18.33
Dividend Yield0%
ROE67.65%
ROA-14.8%
Revenue (TTM)
Revenue Growth
Profit Margin-34.27%
Total Debt
Shares Outstanding0 Cr
Face Value
EPS (TTM)₹0
P/B
Debt / Equity0
50 DMA₹71.33
200 DMA₹41.94
Day change+1.99%
SurveillanceGSM · GSM 0 · ESM · ESM 2
Price Chart
109.09 172.25% · 1Y
109251.1L
2025-07-29
2026-07-29

20-day avg volume: 17K shares

Pros
  • Healthy return on equity of 67.7%.
  • Company is almost debt-free.
  • Revenue grew 154% YoY.
Cons
  • Company is loss-making at the latest annual result.
  • Negative book value per share.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹8 Cr₹9 Cr₹6 Cr₹5 Cr₹2 Cr₹3 Cr₹4 Cr₹3 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-2 Cr₹0 Cr₹-2 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹-1 Cr₹-2 Cr₹-1 Cr₹-1 Cr
EPS
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹12 Cr₹12 Cr₹21 Cr₹26 Cr₹18 Cr₹15 Cr₹11 Cr₹28 Cr
EBITDA₹0 Cr₹0 Cr₹1 Cr₹2 Cr₹1 Cr₹0 Cr₹-5 Cr₹-1 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹0 Cr₹-6 Cr₹-2 Cr
EPS00.211.152.020.38-0.28-34.56-5.6
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹17 Cr₹20 Cr₹21 Cr₹23 Cr₹18 Cr₹18 Cr₹15 Cr₹19 Cr
Total Liabilities₹12 Cr₹15 Cr₹16 Cr₹17 Cr₹12 Cr₹12 Cr₹15 Cr₹21 Cr
Equity₹5 Cr₹5 Cr₹5 Cr₹6 Cr₹6 Cr₹6 Cr₹0 Cr₹-2 Cr
Total Debt
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹4 Cr₹1 Cr₹0 Cr₹0 Cr₹-1 Cr
Investing₹-3 Cr₹-2 Cr₹-1 Cr₹-2 Cr₹-1 Cr
Financing₹0 Cr₹-1 Cr₹0 Cr₹1 Cr₹1 Cr
Free Cash Flow₹4 Cr₹1 Cr₹0 Cr₹0 Cr₹-1 Cr
Shareholding
Promoter 30.8% Institutions 0% Public 69.2%
Efficiency & Working Capital
ROCE-85.8%
Interest Coverage-1.2
Dividend Payout
Debtor Days17 d
Inventory Days43 d
Payable Days132 d
Cash Conversion Cycle-73 d
Working Capital Days59 d
Shareholding Details

As of 2026-06-30

Promoter30.8%
FII0%
DII0%
Institutions0%
Public69.2%
Promoter Pledge0%
No. of Shareholders2,273
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters30.8%30.8%30.8%30.8%30.8%30.8%30.8%30.8%30.8%30.8%30.8%30.8%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public69.2%69.2%69.2%69.2%69.2%69.2%69.2%69.2%69.2%69.2%69.2%69.2%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders1,9732,0022,0992,1852,2462,3342,3562,3772,3992,3932,3882,273
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Alkesh Mahasukhlal GopaniShareholding of Promoter and Promoter Group17.9%6,70,380
Vipul Mahasukhlal GopaniShareholding of Promoter and Promoter Group12.9%4,81,370
Gosalia Meena AlkeshPublic Shareholding12.7%4,74,800
Abhay Chinubhai ShahPublic Shareholding6.6%2,46,580
Umang Alkesh GosaliaPublic Shareholding5.4%2,00,000
Gosalia Nimit PPublic Shareholding2.4%89,900
Rupa Sunil ShahPublic Shareholding1.4%53,520
Pravina Mahasukhlal GopaniShareholding of Promoter and Promoter Group0%700
Mahasukhlal GopaniShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Umang Alkesh GosaliaExecutive Director & MD2025
Ami R ShahIndependent Non Exe. Director2025
Nikhil S. UchatIndependent Non Exe. Director2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10654
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202500000
2025000001
2025000001
Substantial Acquisitions (SAST)

1 disclosure(s)

NULL01/12/2021 · 3,81,170
Company Information
Incorporated1994
AuditorB A Shah S R Mehta & Co
Investor Email[email protected]
🌐 www.parmaxpharma.com

📍 Plot No 20 Survey No 52, Tal Kotda Sangani Hadamtala, Rajkot, Gujarat, 360311

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search

Parmax Pharma Limited Share Price, Market Cap, P/E, Results & Fundamentals — NSE — / BSE 540359 | TipHub